Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Radiotherapy in a multidisciplinary approach]

C Le Péchoux1, R Arriagada

  • 1Service de Radiothérapie A, Institut Gustave-Roussy, Villejuif.

Revue Des Maladies Respiratoires
|August 5, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lung cancer brain metastases management at the dawn of personalized medicine: are we ready to break the barriers?

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same author

Defining the Clinical Target Volume in Postoperative Thymic Epithelial Tumours - A Clinical Practice Guide for UK Clinical Oncologists.

Clinical oncology (Royal College of Radiologists (Great Britain))·2025
Same author

Enhancing radiotherapy with PARP inhibition in soft-tissue sarcomas: a promising synergy requiring specific attention to normal tissues?

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Radiotherapy in the management of lung oligometastases.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2024
Same author

Management of oligometastatic/metastatic sarcomas and place of local treatments with focus on modern radiotherapy approaches.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2024
Same author

Intraoperative motive for incomplete resection in primary retroperitoneal sarcoma.

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2023

Combining thoracic radiotherapy with chemotherapy offers a survival benefit for stage III non-small cell lung cancer patients. New strategies are crucial to improve local control and manage distant metastases effectively.

Area of Science:

  • Oncology
  • Radiation Oncology
  • Medical Oncology

Background:

  • Thoracic radiotherapy is the standard for stage III non-small cell lung cancer (NSCLC).
  • This patient group experiences low cure rates and high metastasis rates.
  • Combined modality treatments are being investigated to improve outcomes.

Purpose of the Study:

  • To review current therapeutic strategies for stage III NSCLC.
  • To explore methods for improving local disease control and managing distant metastases.
  • To assess the efficacy and toxicity of combined radiotherapy and chemotherapy.

Main Methods:

  • Review of randomized trials investigating combined radiotherapy and chemotherapy.
  • Analysis of treatment administration modes (sequential, concurrent, alternating).

Related Experiment Videos

  • Exploration of novel approaches for local control and micrometastasis management.

    • Main Results:

    • Some trials show a 2-4 month median survival benefit with added chemotherapy.
    • Combined treatments aim to enhance local control and systemic disease management.
    • Balancing therapeutic efficacy with increased toxic effects is essential.

    Conclusions:

    • Current combined modality treatments offer modest survival gains for stage III NSCLC.
    • Further research into higher radiation doses, conformal techniques, and novel drugs is needed.
    • Optimizing treatment strategies is critical to improve cure rates and reduce metastasis in NSCLC.